Protocol 1: moderate weight loss (10-15% body weight) Goal: Steady, sustainable weight loss with minimal side effects Tirzepatide approach: Standard escalation to 5-7.5 mg Hold at the dose where you achieve consistent weekly loss of 0.5-1% body weight Expected timeline: 24-36 weeks to target Likely maintenance dose: 5-7.5 mg Retatrutide approach: Standard escalation to 4 mg 4 mg delivered 12.9% weight loss at 24 weeks in trials Hold at 4 mg if achieving target rate Expected timeline: 20-30 weeks to target For moderate goals, both compounds work well at their lower dose ranges
Pricing, specifications, subscription terms, refund policy, and pharmacy network details may change after publication
How Should BPC-157 Arginate Be Tested
Does CJC-1295 increase growth hormone
Learn more about Ethylhexylglycerin Glycerin (or glycerol) is a compound naturally found in your skin
In fact, GHK-Cu outperformed a leading Matrixyl formula in one head-to-head trial(GHK-Cu cut wrinkle volume ~55% vs ~32% vs control serum)